+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Central Nervous System Drugs Market Research Reports

Tourette Syndrome - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Tourette Syndrome - Global Clinical Trials Review, 2024

  • Clinical Trials
  • December 2024
  • 138 Pages
  • Global
From
Alzheimer's Disease (AD): Epidemiology Forecast to 2033 - Product Thumbnail Image

Alzheimer's Disease (AD): Epidemiology Forecast to 2033

  • Report
  • December 2024
  • 49 Pages
  • Global
From
Rett Syndrome: Competitive Landscape - Product Thumbnail Image

Rett Syndrome: Competitive Landscape

  • Report
  • December 2024
  • 66 Pages
  • Global
From
From
Parkinson's Disease: Epidemiology Forecast to 2033 - Product Thumbnail Image

Parkinson's Disease: Epidemiology Forecast to 2033

  • Report
  • November 2024
  • 39 Pages
  • Global
From
Idiopathic Hypersomnia (IH) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Idiopathic Hypersomnia (IH) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • October 2024
  • 55 Pages
  • Global
From
Neurofibromatoses: Competitive Landscape - Product Thumbnail Image

Neurofibromatoses: Competitive Landscape

  • Report
  • October 2024
  • 70 Pages
  • Global
From
Delirium - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Delirium - Global Clinical Trials Review, 2024

  • Clinical Trials
  • August 2024
  • 529 Pages
  • Global
From
Spinal Laminoplasty Market Report and Forecast 2025-2034 - Product Thumbnail Image

Spinal Laminoplasty Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Spinal Cord Stimulation Market Report and Forecast 2024-2032 - Product Thumbnail Image

Spinal Cord Stimulation Market Report and Forecast 2024-2032

  • Report
  • October 2024
  • 250 Pages
  • Global
From
Loading Indicator

The Central Nervous System Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that target the central nervous system. These drugs are used to treat a variety of conditions, including neurological disorders, mental health issues, and pain management. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. The Central Nervous System Drugs market is highly competitive, with companies competing to develop the most effective and safe treatments. Companies in the market are constantly researching and developing new drugs, as well as improving existing treatments. Many of these companies are also involved in clinical trials to test the safety and efficacy of their products. Some of the major companies in the Central Nervous System Drugs market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Johnson & Johnson. These companies are involved in the development and production of a wide range of CNS drugs, including antidepressants, antipsychotics, and anticonvulsants. Show Less Read more